Literature DB >> 17851096

The pharmacokinetics and metabolism of ivermectin in domestic animal species.

Aránzazu González Canga1, Ana M Sahagún Prieto, M José Diez Liébana, Nélida Fernández Martínez, Matilde Sierra Vega, Juan J García Vieitez.   

Abstract

The pharmacokinetic properties of drugs are closely related to their pharmacological efficacy. The kinetics of ivermectin are characterised, in general terms, by a slow absorption process, a broad distribution in the organism, low metabolism, and slow excretion. The kinetics vary according to the route of administration, formulation, animal species, body condition, age, and physiological status, all of which contribute to differences in drug efficacy. Characterisation of ivermectin kinetics can be used to predict and optimise the value of the parasiticide effects and to design programmes for parasite control. This article reviews the pharmacokinetics of ivermectin in several domestic animal species.

Mesh:

Substances:

Year:  2007        PMID: 17851096     DOI: 10.1016/j.tvjl.2007.07.011

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  49 in total

1.  Effect of ivermectin on the integument and dorsoventral muscles of the tick Argas (Persicargas) persicus (Oken) (Ixodoidea: Argasidae).

Authors:  Ashraf A Montasser; Amr Amin
Journal:  Parasitol Res       Date:  2010-07-06       Impact factor: 2.289

2.  Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.

Authors:  Catherine Devine; Gerard P Brennan; Carlos E Lanusse; Luis I Alvarez; Alan Trudgett; Elizabeth Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2010-03-25       Impact factor: 2.289

3.  Ivermectin activates GIRK channels in a PIP2 -dependent, Gβγ -independent manner and an amino acid residue at the slide helix governs the activation.

Authors:  I-Shan Chen; Michihiro Tateyama; Yuko Fukata; Motonari Uesugi; Yoshihiro Kubo
Journal:  J Physiol       Date:  2017-07-30       Impact factor: 5.182

4.  Comparative pharmacokinetics of ivermectin alone and a novel formulation of ivermectin and rafoxanide in calves and sheep.

Authors:  H A El-Banna; A Goudah; H El-Zorba; S Abd-El-Rahman
Journal:  Parasitol Res       Date:  2008-02-23       Impact factor: 2.289

Review 5.  Effect of macrocyclic lactones on nontarget coprophilic organisms: a review.

Authors:  M Junco; L E Iglesias; M F Sagués; I Guerrero; S Zegbi; C A Saumell
Journal:  Parasitol Res       Date:  2021-01-27       Impact factor: 2.289

Review 6.  Toxicology of avermectins and milbemycins (macrocylic lactones) and the role of P-glycoprotein in dogs and cats.

Authors:  Valentina M Merola; Paul A Eubig
Journal:  Vet Clin North Am Small Anim Pract       Date:  2012-03       Impact factor: 2.093

Review 7.  A review on the toxicity and non-target effects of macrocyclic lactones in terrestrial and aquatic environments.

Authors:  Jean-Pierre Lumaret; Faiek Errouissi; Kevin Floate; Jörg Römbke; Keith Wardhaugh
Journal:  Curr Pharm Biotechnol       Date:  2012-05       Impact factor: 2.837

8.  Oral ivermectin as an unexpected initiator of CreT2-mediated deletion in T cells.

Authors:  Evann Corbo-Rodgers; Elizabeth S Staub; Tao Zou; Abigail Smith; Taku Kambayashi; Jonathan S Maltzman
Journal:  Nat Immunol       Date:  2012-02-16       Impact factor: 25.606

Review 9.  Comparative metabolism as a key driver of wildlife species sensitivity to human and veterinary pharmaceuticals.

Authors:  Thomas H Hutchinson; Judith C Madden; Vinny Naidoo; Colin H Walker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-11-19       Impact factor: 6.237

10.  Anthelmintic activity of Artemisia annua L. extracts in vitro and the effect of an aqueous extract and artemisinin in sheep naturally infected with gastrointestinal nematodes.

Authors:  Aida C Cala; Jorge F S Ferreira; Ana Carolina S Chagas; Javier M Gonzalez; Rodney A F Rodrigues; Mary Ann Foglio; Marcia C S Oliveira; Ilza M O Sousa; Pedro M Magalhães; Waldomiro Barioni Júnior
Journal:  Parasitol Res       Date:  2014-05-07       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.